SULFONAMIDE COMPOUNDS AND THEIR USE IN THE MODULATION RETINOID-RELATED ORPHAN RECEPTOR

The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by...

Full description

Saved in:
Bibliographic Details
Main Authors CAMPBELL AMANDA JENNIFER, LE JOELLE, HARRISON STEPHEN, BIRAULT VERONIQUE
Format Patent
LanguageEnglish
Published 28.08.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ wherein R1 to R7 are as defined in claim 35.
AbstractList The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ wherein R1 to R7 are as defined in claim 35.
Author HARRISON STEPHEN
LE JOELLE
CAMPBELL AMANDA JENNIFER
BIRAULT VERONIQUE
Author_xml – fullname: CAMPBELL AMANDA JENNIFER
– fullname: LE JOELLE
– fullname: HARRISON STEPHEN
– fullname: BIRAULT VERONIQUE
BookMark eNqNiksKwjAUALPQhb87PHBdsB_ch-SVBJq8kk-3pUhcSVqo90cLHsDVMMMc2S7POR3Y4GPXkuVGSwRBpqdopQduJQSF2kH0CNpuAoZk7HjQZMFh0Ja0LBx-C0og1yu-dYF9IHdm--f0WtPlxxO7thiEKtIyj2ldpkfK6T1GX93Kpmrq-l7xsv7v-gCmHzN8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2014243362A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2014243362A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:15:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2014243362A13
Notes Application Number: US201214347018
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140828&DB=EPODOC&CC=US&NR=2014243362A1
ParticipantIDs epo_espacenet_US2014243362A1
PublicationCentury 2000
PublicationDate 20140828
PublicationDateYYYYMMDD 2014-08-28
PublicationDate_xml – month: 08
  year: 2014
  text: 20140828
  day: 28
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies GLAXO GROUP LIMITED
RelatedCompanies_xml – name: GLAXO GROUP LIMITED
Score 2.9476864
Snippet The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators of formula (I), processes for their preparation,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title SULFONAMIDE COMPOUNDS AND THEIR USE IN THE MODULATION RETINOID-RELATED ORPHAN RECEPTOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140828&DB=EPODOC&locale=&CC=US&NR=2014243362A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpW9F2ta4PQ7ompZU1KW0z9jaWmIIg3XAV_32TMHVPe8tdICRHfpfcJXcHwH0wdGru1NJ2eMBtL3CFvZB-bQt1PZD8zVObSscOZ8RPmPc6e5p1wMdvLIzJE_ptkiMqRAmF99bo69W_EwuZv5XrB_6uWMuXuBoha2MdO7p88tBC4xHOKaKRFUUjVlqkMH2uN1DqOlS20p66SD9rPODpWMelrLYPlfgY7OdqvKY9AR3Z9MBh9Ft7rQcOss2Tt2pu0Lc-BdOSTWJKwixFGEY0yykjqIQhQbBKcFpAVmKYEk3AjCI2Mf4nWOAqJTRFti6PoRQVpEWehJof4byixRm4i3EVJbaa4PxPHnNWbq9mcA66zbKRFwAGCyVZGXBHCt8TvuDyUdTC1eH_OgtLcAn6u0a62t19DY40qR2q7rAPuu3nl7xRJ3LLb40gfwChw4jI
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMIwpzjedih9TA0rfirartX0Y0jUprbZJ6cfY21hiCoJ0w1X8-yZl0z3tLcnBkRy5z-TuALh3HaNiRiV0g7lMt1yT63NhVzqX5oFg75a8VCp3OCF2WFqv06dpB3xucmHaOqE_bXFEyVFc8nvTyuvlfxALtX8rVw_sQy4tXoJihLS1d2yo9smOhsYjnFJEfc33R2WukayFmdZQimtP-kp70sh-VvyAJ2OVl7LcVirBEdhPJb66OQYdUfdBz9_0XuuDg2T95C2Ha-5bnYBJXsYBJV4SIQx9mqS0JCiHHkGwCHGUwTLHMCJqAhOKyriNP8EMFxGhEdJVewwpqCDN0tBT6z5OC5qdgrsAF36oyw3O_ugxK_Pt0wzPQLde1OIcQHcuKStcZghuW9zmTDzyipsq_V9VYXEvwGAXpsvd4FvQC4sknsURebsChwqkgqumMwDd5utbXEvt3LCblqi_OD-Luw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SULFONAMIDE+COMPOUNDS+AND+THEIR+USE+IN+THE+MODULATION+RETINOID-RELATED+ORPHAN+RECEPTOR&rft.inventor=CAMPBELL+AMANDA+JENNIFER&rft.inventor=LE+JOELLE&rft.inventor=HARRISON+STEPHEN&rft.inventor=BIRAULT+VERONIQUE&rft.date=2014-08-28&rft.externalDBID=A1&rft.externalDocID=US2014243362A1